Skip to main content
Log in

A call for data to inform discussion on cognitive enhancement

  • Response
  • Published:
BioSocieties Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Amarin Corporation. (2008) Amarin to commence phase II trial with AMR101 in age associated memory impairment. January 2010, http://www.amarincorp.com/investor_relations/press-releases/2008/2008-commence-phase2-amr101-age-assoc-mem-impairment.htmlaccessed 6 May 2010.

  • Burgin, A. et al (2009) Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. Nature Biotechnology 28(1): 63–72.

    Article  Google Scholar 

  • Helicon Therapeutics. (2008) Helicon study of HT-0712 on primate memory formation reveals significant enhancement. 22 July, http://www.helicontherapeutics.com/cgi-bin/main.pl?section=News;page=Press_releases, accessed 6 May 2010.

  • Nowotny, H. (2008) Insatiable Curiosity: Innovation in a Fragile Future, Translated by M. Cohen. Cambridge, MA: MIT.

    Google Scholar 

  • Quednow, B.B. (2010) Ethics of neuroenhancement: A phantom debate. BioSocieties 5 (1): 153–156.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nadler, R., Reiner, P. A call for data to inform discussion on cognitive enhancement. BioSocieties 5, 481–482 (2010). https://doi.org/10.1057/biosoc.2010.30

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1057/biosoc.2010.30

Navigation